StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
EDSA

Edesa Biotech, Inc.

EDSA Nasdaq Pharmaceutical Preparations EDGAR ↗
$5.23
+0.12 +2.35%

Key statistics

from XBRL data in SEC filings
Market cap
$46.5M
Revenue (TTM)
$0.00
Net income (TTM)
-$10.4M
EPS (TTM)
$-1.26
P/E ratio
Dividend yield
Free cash flow
Cash
$10.0M
Total assets
$12.4M
Gross margin
52-week range
$0.72 – $20.32

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 11, 2026 8-K Other events Jun 5, 2026 8-K Director or officer change; Shareholder vote results May 29, 2026 8-K Director or officer change May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Other events Feb 24, 2026 10-Q Quarter ended 2025-12-31 Feb 13, 2026 8-K Results of operations (earnings release) Feb 13, 2026 8-K Other events Dec 12, 2025 10-K Fiscal year ended 2025-09-30 Dec 12, 2025 8-K Results of operations (earnings release) Dec 12, 2025 8-K Other events Oct 28, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 30, 2025 8-K Other events Sep 9, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 8, 2025 8-K Director or officer change; Shareholder vote results May 28, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Director or officer change; Other events Apr 4, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 8-K Results of operations (earnings release) Feb 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events Feb 13, 2025 10-K/A Fiscal year ended 2024-09-30 Dec 20, 2024 10-K Fiscal year ended 2024-09-30 Dec 13, 2024 8-K Results of operations (earnings release) Dec 13, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Oct 31, 2024 8-K Entered a material agreement; Terminated a material agreement Oct 4, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 9, 2024 8-K Regulation FD disclosure; Other events Jun 24, 2024 8-K Director or officer change May 30, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 10, 2024 10-Q Quarter ended 2023-12-31 Feb 9, 2024 8-K Results of operations (earnings release) Feb 9, 2024 10-K Fiscal year ended 2023-09-30 Dec 15, 2023 8-K Results of operations (earnings release) Dec 15, 2023 8-K Other events Oct 26, 2023